NovaBay Pharmaceuticals, Inc.
(NYSE Amex Equities : NBY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
TSROTESARO, Inc.
0.08%73.7514.4%$580.57m
AMGNAmgen Inc.
0.10%192.261.2%$565.63m
GILDGilead Sciences, Inc.
1.07%66.270.9%$536.02m
CELGCelgene Corporation
1.14%68.981.2%$526.21m
BIIBBiogen Inc.
1.35%318.781.3%$364.24m
ILMNIllumina, Inc.
-2.04%319.803.5%$343.01m
REGNRegeneron Pharmaceuticals, Inc.
0.09%381.522.6%$273.37m
VRTXVertex Pharmaceuticals Incorporated
-0.61%169.031.9%$225.10m
AAgilent Technologies, Inc.
-0.59%68.951.5%$224.17m
ALXNAlexion Pharmaceuticals, Inc.
2.89%112.592.0%$150.85m
INCYIncyte Corporation
-0.27%66.072.5%$97.49m
EXASExact Sciences Corporation
-0.26%68.1325.3%$93.14m
SRPTSarepta Therapeutics, Inc.
-2.63%116.3815.4%$88.39m
BLUEBluebird Bio, Inc.
2.42%105.8914.4%$82.24m
NKTRNektar Therapeutics
-2.58%35.575.5%$81.91m

Company Profile

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in commercializing and developing products for eye care. Its products include Avenova, NeutroPhase, and CelleRx. The comapny was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.